Kapstone Financial Advisors LLC Makes New $256,000 Investment in Docusign Inc. $DOCU

Key Points

• Kapstone Financial Advisors LLC has invested approximately $256,000 in Docusign Inc., acquiring 3,285 shares during the 2nd quarter.
• Docusign recently reported earnings of $0.92 EPS for the quarter, exceeding analysts' expectations and showing an 8.8% revenue increase year-over-year.
• Institutional investors currently hold 77.64% of Docusign's stock, highlighting significant institutional interest in the company.

Kapstone Financial Advisors LLC purchased a new position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,285 shares of the company's stock, valued at approximately $256,000.

A number of other institutional investors and hedge funds have also made changes to their positions in DOCU. Banque Transatlantique SA purchased a new position in Docusign during the first quarter valued at approximately $26,000. Hemington Wealth Management increased its stake in Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after purchasing an additional 264 shares in the last quarter. Golden State Wealth Management LLC raised its position in shares of Docusign by 519.4% during the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock worth $31,000 after purchasing an additional 322 shares during the period. Summit Securities Group LLC acquired a new position in shares of Docusign during the 1st quarter worth approximately $34,000. Finally, Wood Tarver Financial Group LLC acquired a new position in shares of Docusign during the 4th quarter worth approximately $37,000. 77.64% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Robert Chatwani sold 13,817 shares of the firm's stock in a transaction dated Wednesday, September 17th. The stock was sold at an average price of $83.10, for a total value of $1,148,192.70. Following the transaction, the insider directly owned 71,162 shares in the company, valued at $5,913,562.20. This trade represents a 16.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Anna Marrs sold 728 shares of the firm's stock in a transaction on Monday, September 15th. The stock was sold at an average price of $80.30, for a total value of $58,458.40. Following the transaction, the director owned 10,799 shares in the company, valued at $867,159.70. This trade represents a 6.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 82,533 shares of company stock valued at $6,598,028 in the last 90 days. Insiders own 1.66% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on DOCU shares. Wells Fargo & Company boosted their price target on Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a research note on Friday, September 5th. Zacks Research upgraded Docusign from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, September 9th. Evercore ISI lifted their price target on Docusign from $90.00 to $92.00 and gave the company an "in-line" rating in a report on Friday, September 5th. Citigroup boosted their price objective on Docusign from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, September 4th. Finally, JMP Securities restated a "market outperform" rating and set a $124.00 price target on shares of Docusign in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and fourteen have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $94.14.

Docusign Stock Performance

Docusign stock traded down $0.42 during mid-day trading on Friday, reaching $84.59. 4,516,106 shares of the company were exchanged, compared to its average volume of 3,496,048. The firm has a market cap of $17.01 billion, a P/E ratio of 64.08, a PEG ratio of 4.43 and a beta of 1.02. The business has a fifty day moving average of $76.39 and a 200 day moving average of $79.28. Docusign Inc. has a 12-month low of $57.58 and a 12-month high of $107.86.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.84 by $0.08. The company had revenue of $800.64 million during the quarter, compared to analysts' expectations of $780.35 million. Docusign had a net margin of 9.08% and a return on equity of 14.01%. The firm's revenue for the quarter was up 8.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.97 earnings per share. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. Sell-side analysts predict that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its Board of Directors has initiated a share repurchase program on Thursday, June 5th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to reacquire up to 6.6% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's leadership believes its shares are undervalued.

Docusign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.